Prenatal use of medications for gastroesophageal reflux disease and early childhood fracture risk...ACOG Annual Meeting on September 24, 2017, San Antonio, TX

Background: Gastroesophageal reflux disease is a common condition in pregnancy and is often managed with medications. Specific medications have been linked to osteoporosis and fragility fracture in older adults. This study assessed whether maternal use of antireflux medications is associated with ea...

Descripción completa

Detalles Bibliográficos
Publicado en:Birth: Issues in Perinatal Care Vol. 46; no. 4; pp. 656 - 663
Autores principales: Wolfe, Heather L., Wolfe, Jared A., Ranjit, Anju, Banaag, Amanda, Pérez Koehlmoos, Tracey, Witkop, Catherine T.
Formato: proceedings research tables/charts Journal Article
Publicado: Wiley-Blackwell Dec2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=139725112&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 139725112
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        07307659
        ES5
      jtl: Birth: Issues in Perinatal Care
      issn: 07307659
      maglogo: Y
    pubinfo:
      dt: Dec2019
      vid: 46
      iid: 4
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        139725112
        139725112
        139725112
        10.1111/birt.12423
        139725112
      ppf: 656
      ppct: 7
      formats:
      tig:
        atl: Prenatal use of medications for gastroesophageal reflux disease and early childhood fracture risk...ACOG Annual Meeting on September 24, 2017, San Antonio, TX
      aug:
        au:
          Wolfe, Heather L.
          Wolfe, Jared A.
          Ranjit, Anju
          Banaag, Amanda
          Pérez Koehlmoos, Tracey
          Witkop, Catherine T.
        affil: Department of Obstetrics and Gynecology, Walter Reed National Military Medical Center, Bethesda Maryland
      sug:
        subj:
          Gastroesophageal Reflux Drug Therapy
          Fractures Risk Factors
          Prenatal Exposure Delayed Effects
          Pregnancy
          Female
          Child
          Multivariate Analysis
          Relative Risk
          Confidence Intervals
          Retrospective Design
          Prospective Studies
          Chi Square Test
          Fisher's Exact Test
          Data Analysis Software
          Adolescence
          Adult
          Middle Age
          Comorbidity
          Multiple Birth Offspring
          Congresses and Conferences Texas
          Texas
          Human
          Funding Source
          Child: 6-12 years
          Adolescent: 13-18 years
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Female
      ab: Background: Gastroesophageal reflux disease is a common condition in pregnancy and is often managed with medications. Specific medications have been linked to osteoporosis and fragility fracture in older adults. This study assessed whether maternal use of antireflux medications is associated with early childhood fracture. Methods: TRICARE beneficiaries during pregnancy were retrospectively identified using the Military Health System Data Repository and pharmacy data. Mother and infant data were linked; children with continuous enrollment for the first 5 years of life were included. Differences in the children's fracture risk were analyzed through multivariate analysis, adjusting for region, rank, and military branch of service. Results: A total of 378 150 patients comprised the final cohort with 3.3% (n = 12 479) prescribed antireflux medications during pregnancy. A significant decrease in fracture rate was found among children of women who were prescribed antireflux medications during pregnancy compared with those who were not (0.8% vs 1.2%, RR = 0.70, 95% CI 0.58‐0.85). There was no difference in fracture risk between histamine type 2 receptor antagonists and proton pump inhibitors. A significantly increased fracture incidence was seen in pregnancies with multiple gestations (RR = 1.38, 95% CI 1.04‐1.85). There was no identified difference in fracture risk for women with gestational diabetes, preeclampsia, preterm or low birthweight, chronic hypertension, induction, or breech presentation when compared to women without these conditions. Conclusions: We found no increase in early childhood fracture risk with maternal antireflux medication use. This suggests that prenatal exposure to antireflux medications does not affect fetal bones to a clinically significant extent.
      pubtype: Academic Journal
      doctype:
        proceedings
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N